HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Limited Brands Canada

This article was originally published in The Rose Sheet

Executive Summary

Columbus, Ohio-based company is creating Limited Brands Canada, a Montreal-based division that will support all Limited Brands retail stores and strategic expansion in Canada for brands including Bath & Body Works, Victoria's Secret and lingerie brand La Senza, the firm announces April 14. "We believe a Canadian-based team dedicated to the execution of our brands will provide a foundation for effectively leveraging talent and resources across key operating disciplines," Martin Waters, president of Limited Brands international division, says in the release. Joanne Nemeroff, currently president of La Senza, has been named president of Limited Brands Canada. Limited Brands established a platform for Canadian retail expansion with its purchase of La Senza several years ago. The firm introduced its B&BW brand into Canada in 2008 (1"The Rose Sheet" July 14, 2008)

You may also be interested in...

Bath & Body Works Makes Global Debut With Six Canadian Stores

Inspired by growing brand awareness around the world, beauty retailer Bath & Body Works is expanding outside of the U.S. with the opening of six stores in Canada this fall, Limited Brands announced July 10

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement

The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts